secwatch.observer — SEC 8-K summary
======================================

Issuer:     biote Corp. (BTMD)
CIK:        0001819253
Form:       8-K
Filed at:   2022-11-08T23:59:59+00:00
Accession:  0001193125-22-280186
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biote Q3 revenue $42M (+18% YoY); expects upper end of 2022 guidance
--------------------------------------------------------------------

- Revenue $42.0M, up 18% YoY; net loss $(6.3)M, GAAP diluted EPS $(1.74) due to transaction costs.
- Adjusted EBITDA $12.2M (+19% YoY); expects upper end of 2022 revenue $160-$166M and adj. EBITDA $47-$51M.
- Gross margin improved to 68.2% from 65.4% on favorable product mix.
- Operating income $7.8M, down 13% due to $3.1M transaction and legal costs.
- Cash from operations $6.4M in Q3; sales force expansion on track.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819253/000119312522280186/0001193125-22-280186-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819253/000119312522280186/d402691d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-280186

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer